It’s no secret that our team have been extremely busy here at Arquer Diagnostics in recent months, with so many exciting developments in the pipeline. With that in mind, we thought we’d take a breather to fill you in with everything going on behind the scenes, including the continued worldwide distribution of ADXBLADDER.
ADXBLADDER in Europe
Our urine-based bladder cancer test keeps going from strength to strength, and is now available in 15 regions around the world, with more soon to follow. The Arquer team have been travelling across Europe to support our newly established distributors in setting up validations of ADXBLADDER, in countries such as Spain, Italy and Turkey. You can easily find your nearest distributor via our online interactive map on the Arquer Diagnostics website.
Aside from keeping the wheels in motion with ADXBLADDER, we’ve been thrilled to attend important congresses on both a regional and international level, including BCa18 in Munich at the start of June 2018. This prestigious event is an expert-led educational meeting across two days that focuses solely on bladder cancer, and Arquer were delighted to exhibit and introduce ADXBLADDER to delegates. The end of June was particularly busy as the team arrived in Liverpool to support our UK partner, Alpha Laboratories, at the BAUS Annual Scientific Meeting, only to then jet off to Paris as sponsors of the Updates in Oncourology Course alongside our French partner, Eurobio-Ingen.
The Arquer Diagnostics Team
Our team are always on the go, and it’s our passion for delivering cost-effective healthcare technologies that drives us to keep going. We regularly make time to meet with key opinion leaders both here in the UK and around the world, ensuring to consult with our Medical Advisory Boards at every step of the way. Nadia Whittley, our CEO, along with Tristan Sillars, our Director of Finance and Operations, and other key members of the board are continuing to meet with potential investors to help fuel the next stage here at Arquer Diagnostics, which is very exciting.
Hopefully we’ll have some more exciting updates for you soon, but in the meantime we’re looking forward to BLADDR18 – the upcoming Global Congress on Bladder Cancer in Madrid, Spain. Similarly to BCa18, this major educational multidisciplinary event holds focus solely on bladder cancer, bringing together experts and peers to discuss the challenges we face with when it comes to the management of bladder cancer. Find out more and join us on September 20 – 21 by visiting the BLADDR18 website and registering now!